| Literature DB >> 34423389 |
Junfu Ma1, Qingliang Meng1, Junping Zhan1, Huilian Wang1, Wei Fan1, Yanqi Wang2, Sudan Zhang2, Hua Bian3, Fuzeng Zheng4,5.
Abstract
Paeoniflorin is an active ingredient derived from Paeonia, which has an anti-inflammatory effect. However, the potential role and basis of paeoniflorin in rheumatoid arthritis (RA) are indistinct. Cell viability, cycle distribution, migration, and invasion were evaluated via Cell Counting Kit-8 (CCK-8), flow cytometry, and transwell assays. The contents of inflammatory cytokines were examined using enzyme-linked immunosorbent assay (ELISA). RNA expression levels were determined via qRT-PCR and western blot. The targeting relationship between miR-671-5p and circ-FAM120A (hsa_circ_0003972) or murine double minute 4 (MDM4) was validated via dual-luciferase reporter assay. Paeoniflorin restrained proliferation, migration, invasion, and inflammation and accelerated cell cycle arrest in RA fibroblast-like synoviocytes (RA-FLSs). Circ-FAM120A was boosted in RA synovial tissues and RA-FLSs. Circ-FAM120A upregulation, miR-671-5p knockdown, or MDM4 augmentation reversed the repressive effect of paeoniflorin on RA-FLS progression. Moreover, paeoniflorin attenuated RA-FLS progression by regulating the circ-FAM120A/miR-671-5p/MDM4 axis. Paeoniflorin inhibited RA-FLS proliferation, mobility, and inflammation and triggered cell cycle arrest via mediating the circ-FAM120A/miR-671-5p/MDM4 pathway.Entities:
Keywords: Circ-FAM120A; Paeoniflorin; Rheumatoid arthritis; mDM4; miR-671-5p
Mesh:
Substances:
Year: 2021 PMID: 34423389 DOI: 10.1007/s10753-021-01504-0
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092